VivaLNK this week announced that it has launched its wearable ECG monitor to wirelessly capture ECG and heart rate during a six-minute walk test.
The six-minute walk test is a common exercise routine use in patients with pulmonary hypertension, congestive heart failure, pre-lung transplant evaluation, interstitial lung disease or COPD. The wearable allows for patient monitoring while they walk as far as they can in a six-minute period to assess cardiopulmonary function.
The wearable includes a wearable ECG patch, a specialized mobile app and cloud data services. Patients wear the wireless ECG patch while a clinician monitor and controls the test using a mobile app. Data from the test is consolidated into a centralized database in the cloud for post analysis.
VivaLNK anticipates the wearable to be used for clinical research in a number of applications, including cardiac rehab, digital biomarkers of arrhythmia onset and pharmaceutical clinical trials.
“Medical wearables are making it possible to explore new, potentially meaningful outcomes in clinical studies without adding much additional burden to patients or their clinicians,” Robert Roscigno, VP of clinical development at Gossamer Bio, said in a news release.
